AAAAAA

   
Results: 1-25 | 26-47
Results: 1-25/47
An open letter to the Committee on the Nobel Prize in Medicine
Authors: Abbruzzese, G Agid, Y Albanese, A Alf, C Allen, R Amar, K de Andrade, LA Ang, LC Angelini, C Archer, RL Arunodaya, GR Baltzan, M Baral, K Barnett, H Bergamasco, B Berger, M Bernard, J Bharucha, NE Bhatia, K Blary, N Black, S Bodis-Wollner, I Boyson, SJ Bral-Kulaksizoglu, I Brooks, DJ Brown, JD Burke, RE Calne, DOC Calne, SM Cardoso, F Cardozo-Pelaez, F Chang, YJ Chen, CC Chen, RS Chen, R Chowdhury, A Christie, S Chu, CC Chu, NS Clarida, L Collette, EM Comella, C Conneally, PM Crossman, AR Csanda, E Dalmau, J Dalvi, A De Feijter, A Deecke, L Desai, H De Ybenes, J Dihenia, B Direnfeld, L Dodel, R Donat, J Doudet, D Duane, DD Duff, J Duvoisin, R Eggert, K Elble, RJ Elmer, LW Emre, M Fariello, R Fernendy, HH Findley, LJ Fink, S Freissmuth, M Friedman, JH de la Fuente-Fernandez, R Furtado, S Furukawa, Y Galvez-Jimenez, N Gauthier, S Gawel, MJ Gilman, S Gladstone, RM Goetz, CG Gomori, A Gopinathan, G Gordin, A Gorell, JM Greenamyre, JT Grimes, DA Gurvit, H Guttman, M Guzman, DA Hachinski, V Hanagasi, H Hardy, J Harik, SJ Hassan, MN Hattori, N Hauser, RA Hayashi, H Heller, GL Hobson, D Hochschorner, G Hortnagel, H Horowski, R Howse, DC Huang, CC Huk, II Hurtig, H Hutton, JT Jaffe, ME Jankovic, J Jardine, M Jog, M Johnson, B Kagamihara, Y Karagoz, N Kasper, S Kato, S Kebabian, JW Kertsz, A Khadilkar, SV Kirk, A Kish, S Kitaguchi, T Kofman, OS Koide, R Komori, T Kostyuk, PG Kumar, R Kuo, HC Kurlan, R Kurland, L Kurtuncu, M Lalkaka, JA Lambert, M Landau, W Lang, AE Lassmann, H Lee, CS Lees, AJ Lieberman, A Litvan, I Loeb, C Logan, WJ Lozano, AM Lu, CS Lucy, D Lynch, T Manyam, BV Maraganore, D Marshall, FT Martin, WRW Martin, WE Mathias, C Matsubera, S Mendis, T Menkes, JH Metz, LN Miyazaki, Y Mizuno, Y Mohr, E Moodley, LG Moore, R Morris, JL Muthane, U Nagaraja, D Nair, CPV Narabayashi, H Nomura, Y Norris, JW Obeso, JA O'Brien, C Oertel, W Ohtake, T Okiyama, R Ozdemir, C Pal, PK Panisset, M Paty, DW Paulson, GW Perlmutter, J Pfeiffer, RF Pifl, C Pincus, JH Poewe, W Quinn, N Rajput, AH Rajput, A Ransmayr, G Rascol, O Robinson, R Rocca, WA Roos, RAC Rosenfeld, MR Russell, D Ruth, TJ Ryu, SJ Sachdev, H Safoschnik, G Sahin, H Sanchez-Ramos, J Satishchandra, P Schapira, A",Scheltens,"Schmidley, JW Schnaberth, G Schneider, E Schneider, JS Schutz, W Seeberger, LC Segawa, M Sethi, KD Shah, A Shannon, K Shelton, P Shihabuddin, B Shimizu, T Shinotoh, H Siddique, T Siderowf, A Sieghart, W Simard, A Simmonds, DC Singhal, BS Sluga, E Snow, BJ Soukop, W Sperk, G Spieker, S Steele, JC Stewart, S Stoessl, AJ Subramony, SH Sundaram, M Sung, CY Surya, N Sweet, RD Tabbal, SD Takahashi, H Taniguchi, M Tarsy, D Teravainen, H Tetrud, JW Tolosa, E Tourtellotte, WW Troupin, AS Tsui, JKC Tuite, P Uc, EY Ueki, Y Uitti, R Uyu, C van Hilten, JJ Veerendrakumar, M Veloso, F Viallet, F Voll, C Vrooman, M Wang, X Ward, I Ward, A Waters, C Weng, YH Wenning, GK Williams, BJ Wilson, TW Wolters, EC Wooten, FG Wszolek, Z Yahr, MD Yanagisawa, N Yokochi, F Young, RR Yu, CM Zifko, U
Citation: G. Abbruzzese et al., An open letter to the Committee on the Nobel Prize in Medicine, PARKINS R D, 7(2), 2001, pp. 149-155
Clinical and pathologic features of two groups of patients with dementia with Lewy bodies: Effect of coexisting Alzheimer-type lesion load
Authors: Del Ser, T Hachinski, V Merskey, H Munoz, DG
Citation: T. Del Ser et al., Clinical and pathologic features of two groups of patients with dementia with Lewy bodies: Effect of coexisting Alzheimer-type lesion load, ALZ DIS A D, 15(1), 2001, pp. 31-44
To the editor - Mary Anne Lee
Authors: Hachinski, V
Citation: V. Hachinski, To the editor - Mary Anne Lee, CAN J NEUR, 28(4), 2001, pp. 376-376
Improved outcomes in stroke thrombolysis with pre-specified imaging criteria
Authors: Silver, B Demaerschalk, B Merino, JG Wong, E Tamayo, A Devasenapathy, A O'Callaghan, C Kertesz, A Young, GB Fox, AJ Spence, JD Hachinski, V
Citation: B. Silver et al., Improved outcomes in stroke thrombolysis with pre-specified imaging criteria, CAN J NEUR, 28(2), 2001, pp. 113-119
Physician knowledge of the benefits, risks, and contraindications of tissue plasminogen activator for acute ischemic stroke
Authors: Merino, JG Silver, B Wong, E Demaerschalk, B Tamayo, A Hachinski, V
Citation: Jg. Merino et al., Physician knowledge of the benefits, risks, and contraindications of tissue plasminogen activator for acute ischemic stroke, STROKE, 32(9), 2001, pp. 2208-2209
Recommendations for clinical trial evaluation of acute stroke therapies - Stroke Therapy Academic Industry Roundtable II (STAIR-II)
Authors: Albers, GW Bogousslavsky, J Bozik, MA Brass, LM Broderick, JP Fisher, M Goldstein, LB Salazar-Grueso, E Akitsuki, S Aranko, K Ashwood, T Atkinson, RP Bell, RD Brott, TG Cady, WJ Caplan, LR Coggins, S Cramer, S Cyrus, P Dayno, J Easton, JD Elliott, PJ Finklestein, SP Furlan, AJ Gamzu, E Glasky, MS Gordon, K Gorelick, PB Greenwood, DT Grotta, JC Gunn, K Hachinski, V Hacke, W Hall, ED Hsu, CY Humphreys, DM Ishikawa, H Jacobs, AJ Kaste, M Koroshetz, WJ Krams, M Lauritano, AA Leclerc, J Lees, KR Lesko, L Levine, SR Levy, DE Li, FH Lyden, PD Masayasu, H McDermott, J Meibach, RC Meya, U Miyairi, K Niidome, T Oeda, J Poole, RM Ron, ES Sacco, RL Saltarelli, MD Shimizu, K Shook, BJ Soehngen, M Soehngen, W Stamler, DA Styren, SD Teal, PA Tilley, BC Traystman, RJ Walker, MD Wallin, BA Warach, S Ward, DP Wessel, TC Wettstein, J
Citation: Gw. Albers et al., Recommendations for clinical trial evaluation of acute stroke therapies - Stroke Therapy Academic Industry Roundtable II (STAIR-II), STROKE, 32(7), 2001, pp. 1598-1606
The impact of impact factors
Authors: Hachinski, V
Citation: V. Hachinski, The impact of impact factors, STROKE, 32(12), 2001, pp. 2729-2729
Reporting clinical trials - Full access to all the data
Authors: Rosenberg, RN Aminoff, M Boller, F Griggs, RC Hachinski, V Hallett, M Johnson, RT Kennard, C Lang, AE Lisak, R Newsom-Davis, J Pedley, TA Selzer, ME Zochodne, D
Citation: Rn. Rosenberg et al., Reporting clinical trials - Full access to all the data, STROKE, 32(12), 2001, pp. 2734-2734
New controversy section
Authors: Hachinski, V
Citation: V. Hachinski, New controversy section, STROKE, 32(11), 2001, pp. 2459-2459
Stroke - 30 years of progress
Authors: Hachinski, V
Citation: V. Hachinski, Stroke - 30 years of progress, STROKE, 32(1), 2001, pp. 1-1
Progression of impairment in patients with vascular cognitive impairment without dementia
Authors: Wentzel, C Rockwood, K MacKnight, C Hachinski, V Hogan, DB Feldman, H Ostbye, T Wolfson, C Gauthier, S Verreault, R McDowell, I
Citation: C. Wentzel et al., Progression of impairment in patients with vascular cognitive impairment without dementia, NEUROLOGY, 57(4), 2001, pp. 714-716
Classification of cerebrovascular diseases
Authors: Merino, J Hachinski, V
Citation: J. Merino et V. Hachinski, Classification of cerebrovascular diseases, NEUROPSYCHOLOGY OF CARDIOVASCULAR DISEASE, 2001, pp. 257-277
Study on COgnition and Prognosis in the Elderly (SCOPE): Baseline characteristics
Authors: Hansson, L Lithell, H Skoog, I Baro, F Banki, CM Breteler, M Castaigne, A Correia, M Degaute, JP Elmfeldt, D Engedal, K Farsang, C Ferro, J Hachinski, V Hofman, A James, OFW Krisin, E Leeman, M De Leeuw, PW Leys, D Lobo, A Nordby, G Olofsson, B Opolski, G Prince, M Reischies, FM Rosenfeld, JB Ruilope, L Salerno, J Tilvis, R Trenkwalder, P Zanchetti, A
Citation: L. Hansson et al., Study on COgnition and Prognosis in the Elderly (SCOPE): Baseline characteristics, BLOOD PRESS, 9(2-3), 2000, pp. 146-151
Stroke: Continuity and change
Authors: Hachinski, V
Citation: V. Hachinski, Stroke: Continuity and change, STROKE, 31(7), 2000, pp. 1481-1481
The incidence of dementia in Canada
Authors: McDowell, I Hill, G Lindsay, J Helliwell, B Chappell, N Tuokko, H Beattie, BL Feldman, H Sadovnick, D Gutman, G Hogan, DB Bland, R McCracken, P Newman, S D'Arcy, C Manfreda, J Montgomery, P Strain, L Ostbye, T Steenhuis, R Hachinski, V Chambers, L Raina, P Braun, A Patterson, C Cohen, C Colantonio, A Snow, G Kozak, J Wolfson, C Gauthier, S Bergman, H Panisset, M Ska, B Kergoat, MJ Joanette, Y Hebert, R Verreault, R Durand, P Morin, J Morin, M Bouchard, R Gauvreau, D Fortier, I Balram, C Rockwood, K Graham, J Fisk, J MacKnight, C Nilsson, T Pedlar, D Buehler, S Kozma, A
Citation: I. Mcdowell et al., The incidence of dementia in Canada, NEUROLOGY, 55(1), 2000, pp. 66-73
Prevalence and outcomes of vascular cognitive impairment
Authors: Rockwood, K Wentzel, C Hachinski, V Hogan, DB MacKnight, C McDowell, I
Citation: K. Rockwood et al., Prevalence and outcomes of vascular cognitive impairment, NEUROLOGY, 54(2), 2000, pp. 447-451
Leukoaraiosis - Reifying rarefaction
Authors: Mcrino, JG Hachinski, V
Citation: Jg. Mcrino et V. Hachinski, Leukoaraiosis - Reifying rarefaction, ARCH NEUROL, 57(7), 2000, pp. 925-926
Trauma and multiple sclerosis
Authors: Hachinski, V
Citation: V. Hachinski, Trauma and multiple sclerosis, ARCH NEUROL, 57(7), 2000, pp. 1078-1078
Treatment of ocular myasthenia
Authors: Hachinski, V
Citation: V. Hachinski, Treatment of ocular myasthenia, ARCH NEUROL, 57(5), 2000, pp. 753-753
Whiplash
Authors: Hachinski, V
Citation: V. Hachinski, Whiplash, ARCH NEUROL, 57(4), 2000, pp. 594-594
Levodopa toxicity
Authors: Hachinski, V
Citation: V. Hachinski, Levodopa toxicity, ARCH NEUROL, 57(3), 2000, pp. 410-410
New antiepileptic drugs - Should all be made available?
Authors: Hachinski, V
Citation: V. Hachinski, New antiepileptic drugs - Should all be made available?, ARCH NEUROL, 57(2), 2000, pp. 275-275
The insula and cerebrogenic sudden death
Authors: Cheung, RTF Hachinski, V
Citation: Rtf. Cheung et V. Hachinski, The insula and cerebrogenic sudden death, ARCH NEUROL, 57(12), 2000, pp. 1685-1688
And the controversies go on
Authors: Hachinski, V
Citation: V. Hachinski, And the controversies go on, ARCH NEUROL, 57(12), 2000, pp. 1780-1781
Posttraumatic headache
Authors: Hachinski, V
Citation: V. Hachinski, Posttraumatic headache, ARCH NEUROL, 57(12), 2000, pp. 1780-1780
Risultati: 1-25 | 26-47